Our people

Stephen Bloor

Stephen Bloor

Senior Research Scientist

Biotechnologies

Lipids and Natural Products

Areas of expertise

• Natural products analysis
• Natural products structure characterisation
• Bioactive metabolites
• Formulation of bioactives
• Polar lipids analysis

Qualifications

• PhD Chemistry

Publications

• The novel equisetin-like compound, TA-289, causes aberrant mitochondrial morphology which is independent of the production of reactive oxygen species in Saccharomyces cerevisiae, Quek, N.C.H. Matthews, J.H.; Bloor, S.J., (...), Heathcott, R.W., Atkinson, P.H., Molecular BioSystems, 2013, 9, 2125-2133.
• Efficient Separation and Analysis of Triacylglycerols: Quantitation of β-Palmitate (OPO) in Oils and Infant Formulas, Vyssotski, M.; Bloor, S.J.; Lagutin, K.; Wong, H.; Williams, D.B.G. J Agric Food Chemistry, 2015, 63, 5985-5992.
• Normalization of Hepatic Homeostasis in the Npc1nmf164 Mouse Model of Niemann-Pick Type C Disease Treated with the Histone Deacetylase Inhibitor Vorinostat, Munkacsi, A. B.; Hammond, N, Schneidera, R.T.; Senanayakea, D.S.; Higakic, K.; Kirill Lagutin, K.;, Bloor, S.J., (…). Journal of Biological Chemistry, 2017, 292(11), 4395-4410.
• Antiproliferative activity of New Zealand propolis and phenolic compounds vs human colorectal adenocarcinoma cells, Catchpole, O.; Mitchell, K.; Bloor, S.; Davis, P.; Suddes, A. Fitoterapia, 2015, 106,3257, 167-174
• Anti-gastrointestinal cancer activity of cyclodextrin-encapsulated propolis, Catchpole, O.; Mitchell, K.; Bloor, S.; Davis, P.; Suddes, A. Journal of Functional Foods, 2018, 41, 1-8.